Yahoo Web Search

Search results

    • EMA Authorizes Hemophilia B Gene Therapy

      Medscape· 13 hours ago

      The European Medicines Agency has given the go-ahead for Durveqtix to treat hemophilia B in adults and to Adzynma for patients with congenital thrombotic thrombocytopenic purpura.